Strontium ranelate: New data on fracture prevention and mechanisms of action

Current Osteoporosis Reports

Volumn 7, Issue 3, 2009, Pages 96-102

  Reginster, Jean Yves ^a   Deroisy, Rita ^b   Neuprez, Audrey ^b   Hiligsmann, Mickaël ^b   Zegels, Brigitte ^b   Bruyere, Olivier ^b  

^a Policliniques L BRULL Quai Godefroid Kurth   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COLECALCIFEROL; PLACEBO; STRONTIUM RANELATE;

ALKALINE PHOSPHATASE BLOOD LEVEL; AMNESIA; BONE DENSITY; CLINICAL TRIAL; DERMATITIS; DIARRHEA; DRESS SYNDROME; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; ECZEMA; EOSINOPHILIA; FRACTURE; GASTROINTESTINAL SYMPTOM; HIP FRACTURE; HUMAN; HYPERSENSITIVITY REACTION; JAW OSTEONECROSIS; LUNG EMBOLISM; NAUSEA; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; PREVALENCE; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SIDE EFFECT; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; TREATMENT DURATION; VENOUS THROMBOEMBOLISM; VERTEBRA FRACTURE; VERTEBRA MALFORMATION;

BONE DENSITY CONSERVATION AGENTS; FRACTURES, BONE; HUMANS; ORGANOMETALLIC COMPOUNDS; OSTEOPOROSIS; THIOPHENES; TREATMENT OUTCOME;

EID: 72449204568     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-009-0016-1     Document Type: Review

References (40)

1. J.A. Kanis N. Burlet C. Cooper, et al. 2008 European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos Int 19 399 428 18266020 10.1007/s00198-008-0560-z 1:STN:280:DC%2BD1c3itFekuw%3D%3D
2. A. Suzuki S. Sekiguchi S. Asano M. Itoh 2008 Pharmacological topics of bone metabolism: recent advances in pharmacological management of osteoporosis J Pharmacol Sci 106 530 535 18431035 10.1254/jphs.FM0070218 1:CAS:528: DC%2BD1cXltlCjsrk%3D (Pubitemid 351556228)
3. S. Adami S. Giannini G. Bianchi, et al. 2009 Vitamin D status and response to treatment in post-menopausal osteoporosis Osteoporos Int 20 239 244 18551242 10.1007/s00198-008-0650-y 1:CAS:528:DC%2BD1MXktVSgtA%3D%3D
4. V. Rabenda J. Vanoverloop V. Fabri, et al. 2008 Low incidence of anti-osteoporosis treatment after hip fracture J Bone Joint Surg Am 90 2142 2148 18829912 10.2106/JBJS.G.00864
5. J.Y. Reginster O. Malaise A. Neuprez O. Bruyere 2007 Strontium ranelate in the prevention of osteoporotic fractures Int J Clin Pract 61 324 328 17263720 10.1111/j.1742-1241.2006.01249.x 1:CAS:528:DC%2BD2sXjs1Wks7w%3D (Pubitemid 46271298)
6. P.J. Meunier C. Roux E. Seeman, et al. 2004 The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis N Engl J Med 350 459 468 14749454 10.1056/NEJMoa022436 1:CAS:528:DC%2BD2cXos1Snsw%3D%3D (Pubitemid 38133766)
7. E. Canalis M. Hott P. Deloffre, et al. 1996 The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro Bone 18 517 523 8805991 10.1016/8756-3282(96)00080-4 1:CAS:528:DyaK28Xkslagu7k%3D (Pubitemid 26257871)
8. R. Baron Y. Tsouderos 2002 In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation Eur J Pharmacol 450 11 17 12176103 10.1016/S0014-2999(02)02040-X 1:CAS:528:DC%2BD38XmtlKjsb8%3D (Pubitemid 34899590)
9. N. Takahashi T. Sasaki Y. Tsouderos T. Suda 2003 S 12911-2 inhibits osteoclastic bone resorption in vitro J Bone Miner Res 18 1082 1087 12817762 10.1359/jbmr.2003.18.6.1082 1:CAS:528:DC%2BD3sXkslOhsbk%3D (Pubitemid 37294946)
10. A.S. Hurtel-Lemaire R. Mentaverri A. Caudrillier, et al. 2009 The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways J Biol Chem 284 575 584 18927086 10.1074/jbc.M801668200 1:CAS:528:DC%2BD1cXhsFCjtLjM
11. D.L. Kendler 2006 Strontium ranelate-data on vertebral and nonvertebral fracture efficacy and safety: mechanism of action Curr Osteoporos Rep 4 34 39 16527006 10.1007/s11914-006-0013-6 (Pubitemid 44623946)
12. P.J. Marie M. Hott D. Modrowski, et al. 1993 An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats J Bone Miner Res 8 607 615 8511988 1:CAS:528:DyaK2cXksFSjsbs%3D
13. T. Morohashi T. Sano K. Harai S. Yamada 1995 Effects of strontium on calcium metabolism in rats. II. Strontium prevents the increased rate of bone turnover in ovariectomized rats Jpn J Pharmacol 68 153 159 7563972 10.1254/jjp.68.153 1:CAS:528:DyaK2MXmsFequ74%3D
14. P.J. Meunier D.O. Slosman P.D. Delmas, et al. 2002 Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis-a 2-year randomized placebo controlled trial J Clin Endocrinol Metab 87 2060 2066 11994341 10.1210/jc.87.5.2060 1:CAS:528:DC%2BD38XjsFGhtL4%3D (Pubitemid 34521489)
15. D. Farlay G. Boivin G. Panczer, et al. 2005 Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone J Bone Miner Res 20 1569 1578 16059629 10.1359/JBMR.050405 1:CAS:528:DC%2BD2MXhtVOltrvO (Pubitemid 41243546)
16. J.Y. Reginster E. Seeman M.C. De Vernejoul, et al. 2005 Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study J Clin Endocrinol Metab 90 2816 2822 15728210 10.1210/jc.2004-1774 1:CAS:528: DC%2BD2MXkt1Wgt78%3D (Pubitemid 40686329)
17. J.Y. Reginster D. Felsenberg S. Boonen, et al. 2008 Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebocontrolled trial Arthritis Rheum 58 1687 1695 18512789 10.1002/art.23461 1:CAS:528:DC%2BD1cXotVOntrg%3D (Pubitemid 351847521)
18. P.J. Meunier J.Y. Reginster 2003 Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis Osteoporos Int 14 Suppl3 S66 S76 12730769 1:CAS:528:DC%2BD3sXjslWhs7k%3D
19. H.K. Genant C.Y. Wu C. van Kuijk M.C. Nevitt 1993 Vertebral fracture assessment using a semiquantitative technique J Bone Miner Res 8 1137 1148 8237484 1:STN:280:DyaK2c%2FlsFyhuw%3D%3D
20. P.J. Meunier C. Roux S. Ortolani 2002 Strontium ranelate reduces the vertebral fracture risk in women with postmenopausal osteoporosis Osteoporos Int 13 45
21. C. Roux J.Y. Reginster J. Fechtenbaum, et al. 2006 Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors J Bone Miner Res 21 536 542 16598373 10.1359/jbmr.060101 1:CAS:528:DC%2BD28Xkt1Kqsrc%3D
22. M. Naves J.B. Diaz-Lopez C. Gomez, et al. 2003 The effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a Spanish population Osteoporos Int 14 520 524 12730754 10.1007/s00198-003-1405-4 1:STN:280:DC%2BD3szitFyrsw%3D%3D (Pubitemid 36919214)
23. T.P. van Staa H.G. Leufkens C. Cooper 2002 Does a fracture at one site predict later fractures at other sites? A British cohort study Osteoporos Int 13 624 629 12181620 10.1007/s001980200084 (Pubitemid 34885853)
24. C. Roux J. Fechtenbaum S. Kolta, et al. 2008 Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis Ann Rheum Dis 67 1736 1738 18713788 10.1136/ard.2008.094516 1:STN:280:DC%2BD1cjjsVersw%3D%3D
25. Author N: 2002 PDotDoEaSAotNS. World population prospects: the 2002 revision and world urban prospects. In; 2008. ##Available at URL.## ##Accessed DATE.## or ##City of Publication: Publisher; Year of Publication.##
26. M.P. Ettinger 2003 Aging bone and osteoporosis: strategies for preventing fractures in the elderly Arch Intern Med 163 2237 2246 14557222 10.1001/archinte.163.18.2237 (Pubitemid 37248789)
27. M.R. McClung P. Geusens P.D. Miller, et al. 2001 Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group N Engl J Med 344 333 340 11172164 10.1056/NEJM200102013440503 1:CAS:528:DC%2BD3MXht1Wlu7g%3D (Pubitemid 32107641)
28. E. Seeman B. Vellas C. Benhamou, et al. 2006 Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older J Bone Miner Res 21 1113 1120 16813532 10.1359/jbmr.060404 1:CAS:528:DC%2BD28XntlWqu7k%3D (Pubitemid 43962840)
29. E. Seeman J.P. Devogelaer R. Lorenc, et al. 2008 Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia J Bone Miner Res 23 433 438 17997711 10.1359/jbmr.071105 1:CAS:528:DC%2BD1cXjsl2itbo%3D (Pubitemid 351304674)
30. O. Malaise O. Bruyere J.Y. Reginster 2007 Strontium ranelate normalizes bone mineral density in osteopenic patients Aging Clin Exp Res 19 330 333 17726365
31. O. Bruyere C. Roux J. Detilleux, et al. 2007 Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate J Clin Endocrinol Metab 92 3076 3081 17566094 10.1210/jc.2006-2758 1:CAS:528:DC%2BD2sXptl2hsb0%3D (Pubitemid 47236373)
32. J.Y. Reginster P.J. Meunier 2003 Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies Osteoporos Int 14 Suppl3 S56 S65 12730797 1:CAS:528:DC%2BD3sXjslWhs7g%3D
33. O. Bruyere C. Roux J. Badurski, et al. 2007 Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate Curr Med Res Opin 23 3041 3045 17967221 10.1185/030079907X242818 1:CAS:528:DC%2BD1cXhslOksLs%3D
34. M.E. Arlot Y. Jiang H.K. Genant, et al. 2008 Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate J Bone Miner Res 23 215 222 17922612 10.1359/jbmr.071012 1:CAS:528:DC%2BD1cXhvVOhtr8%3D (Pubitemid 351160035)
35. P. Marquis P. Cialdella C. De la Loge 2001 Development and validation of a specific quality of life module in post-menopausal women with osteoporosis: the QUALIOST Qual Life Res 10 555 566 11789555 10.1023/A:1013041206433 1:STN:280:DC%2BD38%2FmtlKrtA%3D%3D (Pubitemid 34015512)
36. P. Marquis C. Roux C. De la Loge, et al. 2008 Strontium ranelate prevents quality of life imparment in post-menopausal women with established vertebral osteoporosis Osteoporos Int 19 503 510 17929073 10.1007/s00198-007-0464-3 1:CAS:528:DC%2BD1cXkslOksL0%3D
37. Shea B, Wells G, Cranney A, et al.: Calcium supplementation on bone loss in postmenopausal women. Cochrane Database Syst Rev 2004:CD004526.
38. (EMEA) EMA. Question and answers on the safety of Protelos/Osseor (strontium ranelate). In; 2007.
39. A. Grosso I. Douglas A. Hingorani, et al. 2008 Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions Br J Clin Pharmacol 66 689 694 18754840 1:CAS:528:DC%2BD1cXhsVyntb7M
40. S. Tas T. Simonart 2003 Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update Dermatology 206 353 356 12771485 10.1159/000069956 1:STN:280:DC%2BD3s3kslCmuw%3D%3D (Pubitemid 36677029)